Everyone who spends time outdoors in the Northeast and Midwest in summer knows to check for ticks. The dominant worry is Lyme disease — and rightly so, given that an estimated 500,000 Americans contract it annually. But the same black-legged ticks (Ixodes scapularis) that transmit Borrelia burgdorferi also carry a virus that is, by many clinical measures, far more devastating: Powassan virus, a tick-borne flavivirus that causes brain infection, kills approximately one in ten people who develop neurological disease, and leaves approximately half of all survivors with permanent neurological damage.
And unlike Lyme disease — which requires the tick to be attached for 36 to 48 hours before the Borrelia bacteria can transmit — Powassan virus can be transmitted in as little as 15 minutes of tick attachment. Diligent tick checks after outdoor activity will not reliably prevent Powassan exposure. The tick that has been attached long enough to transmit the virus may still be small enough to miss on a body inspection.
Nationally, approximately 239 Powassan virus disease cases were reported over the past 10 years, with cases concentrated in the Northeast and Great Lakes states — New York, Massachusetts, Connecticut, New Jersey, Pennsylvania, Michigan, Wisconsin, and Minnesota. In New York State alone, 1 to 9 cases are reported in most years. The trend line has been consistently upward over the past decade, consistent with the documented expansion of Ixodes scapularis range and tick density. With 2026 already confirmed as one of the worst tick seasons in years — Lyme disease ER visits are up 25 percent over the prior year, and in Connecticut, 40 percent of submitted ticks are testing positive for Lyme — the conditions for Powassan exposure are at elevated levels.
What Powassan Virus Does to the Brain
Powassan virus is a member of the tick-borne encephalitis (TBE) serocomplex — the same viral family responsible for tick-borne encephalitis in Europe and Asia, for which a vaccine is available internationally (though not yet routinely in the United States). Most people infected with Powassan virus — estimated at somewhere between 90 and 95 percent of infected individuals — experience either no symptoms or only mild flu-like illness. They recover fully and are never diagnosed.
The 5 to 10 percent of infected individuals who develop neurological disease, however, face a profoundly dangerous clinical situation. Powassan encephalitis can present with fever, severe headache, vomiting, weakness, confusion, loss of coordination, speech difficulties, and seizures. Progression from early symptoms to coma can occur within hours to days. MRI of the brain characteristically shows hyperintensities — areas of abnormal signal — in the white matter and deep brain structures, including the thalamus, basal ganglia, and brainstem. These findings confirm viral inflammation of the brain parenchyma.
The clinical outcomes for severe Powassan encephalitis are grim by modern standards. Approximately 10 percent of Powassan neuroinvasive disease cases are fatal. Of survivors, approximately half are left with permanent neurological deficits — including chronic headaches, muscle weakness, focal paralysis, cognitive impairment, and in severe cases, long-term memory dysfunction or personality changes. These outcomes are not rare complications of an otherwise benign infection. They are the expected consequence of neurological disease in a majority of patients who develop it.
There is no vaccine approved in the United States for Powassan virus. There is no antiviral treatment. Management is entirely supportive — intensive care, mechanical ventilation if needed, seizure control, and rehabilitation for survivors. This means that for Powassan, prevention — specifically, preventing tick bites — is the only tool available.
Two Lineages and the Deer Tick Virus
Powassan virus has two distinct lineages that are ecologically distinct but clinically similar. Lineage I is associated with the groundhog tick (Ixodes cookei), which more commonly bites wildlife and less commonly bites humans. Lineage II, known as Deer Tick Virus (DTV), circulates in Ixodes scapularis — the same black-legged deer tick responsible for Lyme disease, anaplasmosis, babesiosis, and ehrlichiosis. DTV is the lineage most commonly responsible for human neurological disease in Lyme-endemic areas of the Northeast, and its increasing detection in tick populations in New England and the Mid-Atlantic is driving the rising human case trend.
The practical consequence for outdoor recreationists in the Northeast is stark: the same tick bite that might give you Lyme disease could simultaneously transmit Powassan/DTV, Anaplasma phagocytophilum (anaplasmosis), Babesia microti (babesiosis), or multiple pathogens at once — co-infections that complicate diagnosis and treatment. Prevention of all of these conditions converges on the same strategies: use EPA-registered tick repellents, wear permethrin-treated clothing, do thorough tick checks after outdoor activity (removing ticks as promptly as possible), and seek medical care for any unexplained fever, severe headache, or neurological symptoms within weeks of potential tick exposure.
Frequently Asked Questions
Q: What is Powassan virus?
A: Powassan virus is a tick-borne flavivirus transmitted by black-legged ticks (Ixodes scapularis) and other Ixodes species. It can cause viral encephalitis — brain inflammation — and is the most dangerous tick-borne pathogen in North America.
Q: How quickly can Powassan virus be transmitted by a tick?
A: As quickly as 15 minutes of tick attachment — far faster than Lyme disease, which requires 36–48 hours. This makes tick removal speed less protective against Powassan than against Lyme.
Q: What are the outcomes for Powassan encephalitis?
A: Approximately 10% of cases are fatal. About 50% of survivors have permanent neurological deficits including chronic headaches, weakness, paralysis, or cognitive impairment.
Q: Is there a vaccine or treatment for Powassan virus?
A: No vaccine is approved in the United States. No specific antiviral treatment exists. Management is supportive. Prevention via tick bite avoidance is the only protective strategy.
Q: Where in the United States does Powassan virus circulate?
A: Predominantly in the Northeast and Great Lakes states — New York, Connecticut, Massachusetts, New Jersey, Pennsylvania, Michigan, Wisconsin, and Minnesota — wherever Ixodes scapularis ticks are endemic.
